These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18205555)
1. Do advertisements in clinical software influence prescribing? Mansfield PR Med J Aust; 2008 Jan; 188(1):13-4. PubMed ID: 18205555 [TBL] [Abstract][Full Text] [Related]
2. The effect of advertising in clinical software on general practitioners' prescribing behaviour. Henderson J; Miller G; Pan Y; Britt H Med J Aust; 2008 Jan; 188(1):15-20. PubMed ID: 18205556 [TBL] [Abstract][Full Text] [Related]
3. The effect of advertising in clinical software on general practitioners' prescribing behaviour. Reeve JF; Mackson JM; Sweidan M; Williamson M Med J Aust; 2008 Jul; 189(2):85. PubMed ID: 18637774 [No Abstract] [Full Text] [Related]
4. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801 [TBL] [Abstract][Full Text] [Related]
5. The influences of drug companies' advertising programs on physicians. Güldal D; Semin S Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183 [TBL] [Abstract][Full Text] [Related]
6. Consumers' reports on the health effects of direct-to-consumer drug advertising. Weissman JS; Blumenthal D; Silk AJ; Zapert K; Newman M; Leitman R Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-82-95. PubMed ID: 14527237 [TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical company influence on nonsteroidal anti-inflammatory drug prescribing behaviors. Naik AD; Woofter AL; Skinner JM; Abraham NS Am J Manag Care; 2009 Apr; 15(4):e9-15. PubMed ID: 19341315 [TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples. Khazzaka M BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295 [TBL] [Abstract][Full Text] [Related]
9. [Drug prescriptions: an epidemiological survey of French general practitioners]. Durieux P Presse Med; 2000 Jun; 29(20):1126-7. PubMed ID: 10901792 [No Abstract] [Full Text] [Related]
10. Trends in antihypertensive drug advertising, 1985-1996. Wang TJ; Ausiello JC; Stafford RS Circulation; 1999 Apr; 99(15):2055-7. PubMed ID: 10209012 [TBL] [Abstract][Full Text] [Related]
11. Bevacizumab prescribing practices for epithelial ovarian cancer in Australia. Burdett N; Kichenadasse G Intern Med J; 2019 Oct; 49(10):1334-1335. PubMed ID: 31602777 [No Abstract] [Full Text] [Related]
12. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263 [TBL] [Abstract][Full Text] [Related]
13. Prescription Opioid Misuse and Overuse in the U.S. Fleming DA Mo Med; 2018; 115(3):189-190. PubMed ID: 30228715 [No Abstract] [Full Text] [Related]
14. Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions. Onishi E; Kobayashi T; Dexter E; Marino M; Maeno T; Deyo RA J Am Board Fam Med; 2017; 30(2):248-254. PubMed ID: 28379832 [TBL] [Abstract][Full Text] [Related]
15. Direct-to-consumer advertising. Graham JR CMAJ; 2004 Mar; 170(5):768-70; author reply 770-1. PubMed ID: 14993155 [No Abstract] [Full Text] [Related]
17. Pharmaceutical care and its relationship to prescribing behaviour of general practitioners. Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA Pharm World Sci; 2006 Oct; 28(5):302-8. PubMed ID: 17111244 [TBL] [Abstract][Full Text] [Related]